Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Restasis
Pharma
Russia's war in Ukraine could hamper Viatris' future earnings
Viatris’ business avoided a hit from Russia’s war in Ukraine for the first three months of 2022, but that could change.
Fraiser Kansteiner
May 9, 2022 11:05am
The top 10 drugs losing US exclusivity in 2022
Mar 8, 2022 3:00am
Lumenis taps 'This Is Us' star Mandy Moore for dry eye DTC spot
Feb 14, 2022 8:20am
AbbVie's blockbuster eye drug Restasis under threat
Feb 2, 2022 4:09pm
In a first, FDA approves nasal spray to treat dry eye disease
Oct 19, 2021 7:40am
AbbVie puts 17-year-old Restasis brand back on TV
Apr 26, 2021 8:35am
